These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7887368)
1. OTC switch considered for asthma. Am Pharm; 1995 Jan; NS35(1):10. PubMed ID: 7887368 [No Abstract] [Full Text] [Related]
2. Making the most of the Rx-OTC switch. An interview with Charles A. Pergola [by John Covert]. Pergola CA Am Pharm; 1984 Feb; NS24(2):34-8. PubMed ID: 6702589 [No Abstract] [Full Text] [Related]
3. Rx-to-OTC shift: not for these widely used drugs. Chase SL RN; 1995 Jan; 58(1):67. PubMed ID: 7624708 [No Abstract] [Full Text] [Related]
4. Rx drugs switched to OTC. FDA Drug Bull; 1983 Nov; 13(3):29-30. PubMed ID: 6653955 [No Abstract] [Full Text] [Related]
5. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. Spencer HM Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546 [No Abstract] [Full Text] [Related]
7. The debate continues on OTC switches. Giaquinta D Manag Care Interface; 2003 Jun; 16(6):49-50. PubMed ID: 12841076 [No Abstract] [Full Text] [Related]
8. The American College of Allergists and the Food and Drug Administration. Boggs PB Ann Allergy; 1986 Jun; 56(6):443. PubMed ID: 3717709 [No Abstract] [Full Text] [Related]
9. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition. Kraushaar KJ Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581 [No Abstract] [Full Text] [Related]
10. Prescription to over-the-counter drug switches. Rheinstein PH Am Fam Physician; 1997 Sep; 56(4):1211-4. PubMed ID: 9310067 [No Abstract] [Full Text] [Related]
11. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability? Shiffman S; Sweeney CT Health Policy; 2008 Apr; 86(1):17-26. PubMed ID: 17935827 [TBL] [Abstract][Full Text] [Related]
12. No doctor required. The FDA may expand the number of prescription drugs it converts to over-the-counter use. Thompson M Time; 2000 Jul; 156(3):38. PubMed ID: 11009720 [No Abstract] [Full Text] [Related]
13. Steps taken to lessen tampering with OTC drugs. FDA Drug Bull; 1983 Apr; 13(1):6. PubMed ID: 6852409 [No Abstract] [Full Text] [Related]
14. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Sullivan PW; Nair KV; Patel BV Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556 [TBL] [Abstract][Full Text] [Related]
15. Economic aspects of drug over use. Rucker TD Med Ann Dist Columbia; 1973 Dec; 42(12):609-14. PubMed ID: 4520521 [No Abstract] [Full Text] [Related]
16. Abuse of OTC medications, prescription drugs raises concern. Langford RE Occup Health Saf; 2001 Dec; 70(12):8. PubMed ID: 11799566 [No Abstract] [Full Text] [Related]
18. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Jan; 67(15):3060-76. PubMed ID: 11820251 [TBL] [Abstract][Full Text] [Related]
19. Direct-to-OTC marketing of drugs: possible approaches. Mahinka SP; Bierman ME Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985 [No Abstract] [Full Text] [Related]
20. FDA considers OTC drug labeling reform. Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722 [No Abstract] [Full Text] [Related] [Next] [New Search]